Skip to main content
Equibles

MetLife Investment Management, LLC

Position in SCLX — Scilex Holding Co

CIK 1529735 Whippany, NJ
Back to SCLX Full portfolio

Position in SCLX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$8,502
+$1,243 QoQ
Shares Held
1,090
-37.7% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 72 holders
Holding Since
Mar 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SCLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $750,511,239 across 12 Drug Manufacturers - General names. SCLX ranks #12 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 212,458 $254,828,520
2 JNJ
Johnson & Johnson
 550,760 $139,876,517
3 ABBV
AbbVie Inc.
 409,814 $103,125,594
4 MRK
Merck & Co., Inc.
 565,110 $72,616,635
5 AMGN
Amgen Inc
 138,472 $50,143,480
6 GILD
Gilead Sciences, Inc.
 284,053 $35,887,256
7 PFE
Pfizer Inc
 1,303,824 $31,396,081
8 AZN
Astrazeneca PLC
 149,538 $28,355,395

All Filings in SCLX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,502 1,090
2026-03-31 $7,259 1,090
2025-12-31 $13,297 1,090
2025-09-30 $21,451 1,090
2025-06-30 $6,425 1,091
2025-03-31 $9,521 38,241
2024-12-31 $16,290 38,241
2024-09-30 $35,372 38,241
2024-06-30 $73,805 38,241
2024-03-31 $54,390 34,208
2023-12-31 $69,784 34,208
2023-06-30 $190,538 34,208
2023-03-31 $280,505 34,208